异位综合征:产前诊断、伴随畸形与结局
这项回顾性研究分析了2014年1月至2021年1月在一家三级中心产前超声诊断的62例异位综合征胎儿,其中右房异构32例(51.6%)、左房异构30例(48.4%)。右房异构组和左房异构组的心外畸形发生率分别为25%和44%(p=0.13)。单心室修复患者的儿童期死亡率高于双心室修复患者(p=0.031),圆锥动脉干畸形是影响死亡率的独立因素(HR=5.09,95%CI 1.09-23.71,p=0.039)。
要点
- 右房异构与左房异构的心外畸形发生率分别为25%和44%,差异无统计学显著(p=0.13)。
- 单心室修复患者的儿童期死亡率高于双心室修复患者(p=0.031)。
- 圆锥动脉干畸形是影响死亡率的独立因素(HR=5.09,95%CI 1.09-23.71,p=0.039)。
核心结论
- 胎儿水肿、单心室生理和圆锥动脉干畸形与异位综合征的不良结局相关。
- 心脏畸形的严重程度是结局的主要决定因素。
- 心外畸形的存在与发病率和死亡率增加相关。
研究设计与样本
- 回顾性研究,分析2014年1月至2021年1月在一家三级中心产前超声诊断的异位综合征胎儿,共62例,分为右房异构组32例(51.6%)和左房异构组30例(48.4%)。
主要发现
- 右房异构组心外畸形发生率为25%,左房异构组为44%(p=0.13)。
- 单心室修复患者的儿童期死亡率高于双心室修复患者(p=0.031)。
- 圆锥动脉干畸形是影响死亡率的独立因素(HR=5.09,95%CI 1.09-23.71,p=0.039)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study is to define cardiac and extracardiac malformations in fetuses with heterotaxy syndrome and to determine perinatal and childhood prognosis. METHODS: In this retrospective study, fetuses diagnosed with heterotaxy syndrome on antenatal ultrasonography in a tertiary center between January 2014 and January 2021 were analyzed. Fetuses with heterotaxy syndrome were grouped as right atrial isomerism (RAI) and left atrial isomerism (LAI). RESULTS: A total of 62 fetuses, 32 (51.6%) with RAI and 30 (48.4%) with LAI, were included in the study. Extracardiac anomaly was detected in 25% of fetuses with RAI and 44% of fetuses with LAI (p = 0.13). Patients with univentricular repair had a higher childhood mortality than patients with biventricular repair (p = 0.031). The presence of conotruncal anomaly was an independent factor affecting mortality (HR = 5.09, CI 95% 1.09-23.71, p = 0.039). CONCLUSION: Hydrops fetalis, univentricular physiology and conotruncal anomalies are associated with poor outcomes in heterotaxy syndrome. The severity of the cardiac malformation is the main determinant of the outcomes. The presence of extracardiac malformations is associated with increased morbidity and mortality.
引用
- Akalın M, Demirci O, Kumru P, et al. Heterotaxy syndrome: Prenatal diagnosis, concomitant malformations and outcomes. Prenat Diagn. 2022. PMID: 35102577. doi:10.1002/pd.6110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。